Academy of Pharmaceutical Sciences

John Wahlich, Jayne Lawrence, Eddie French1

APS Mission and Aims

• Mission:– Championing innovation and opportunity in

Pharmaceutical Sciences for the delivery of medicines• Aims– Promote the Pharmaceutical Sciences to stakeholdersto facilitate understanding and achieve engagement– Share learning, drive collaboration, partnership andinnovation– Deliver insights into industry and academic roles foremerging scientists

2

APS Strategic ThemesThe mission of the Academy of Pharmaceutical Sciences is to champion innovation

and opportunity in Pharmaceutical Sciences for the delivery of medicines.

Influence Policy

•More investment in Pharm Sciences in UK•APS view sought by policy makers and TSB•APS recognised as only professional group representing Pharm Sciences•Senior Executives recognise the influence from and return on investment in APS

Promote Careers

•Strengthen training and development of young scientists by supporting early career development•Build APS membership amongst students•Mentor post-grads and PhDs in academia•Establish connection with TSB for research projects

Further Scientific

knowledge

•Support Focus Groups to further scientific knowledge• Increase quantity of hard outputs/papers• Influence direction of research funding

Represent Pharma Sciences

•Establish APS reputation for balanced independent view of Pharm Sciences in UK•Extend representation through engagement with pharma ‘mid tier’, CROs, CMOs and SMEs• Increase membership amongst pharma scientist population

APS Enablers Increase

organisational membership

Robust sponsorship income streams

Clear APS brand definition

3

Focus Group Current Chairperson(s) Emerging Scientists and Development Helen Barker / Claire

Thompson / Geoff DavisonBiomolecules and Vaccines Kevin KingBiopharmaceutics and oral drug delivery

Mark McAllister

Inhalation Eddie FrenchMaterial Sciences Michael LeanePharmacognosy Michael Heinrich Process Engineering, Product Formulation and Manufacturing

Kendal Pitt

Anti-infectives (Microbiology) Brendan GilmoreSkin Forum Majella Lane

APS Focus Groups

4

APS

• The APS is a not-for-profit organisation funded through membership and sponsorship

• Of attendees today less than 25% are members of APS

• If you like what we’re doing and want to support the Pharmaceutical Sciences in the UK join the APS!– £60 / year or £15 for studentshttp://www.apsgb.co.uk/default.asp

5

Medicines for Older Adults

• Meeting Stevenage 13 March 2013Medicines for older adults: Learning from practice to develop patient centric drug products• Jointly organised by the Academy of Pharmaceutical Sciences

(APS), the Geriatric Medicine Society and UCL School of Pharmacy

• The event created the platform to discuss the provision of medicines for older adults from a pharmaceutical sciences perspective

• Meeting commentary Int J Pharm. 2013 Nov 1;456(1):251-7. doi: 10.1016/j.ijpharm.2013.07.038. Epub 2013 Aug 3. (35 references)

6

Medicines for Older Adults

• Meeting discussed– Demographics of older adults– Physiological aspects of ageing– Medicines and ageing from a clinical, pharmacy and regulatory

perspective– ADRs, polypharmacy, adherence, formulation and delivery aspects

• Conclusion– Parallels with paediatric medicines– More could be done to improve the delivery of medicines to older

adults– Opportunity for collaboration to achieve this

‘The use of medications in older patients is arguably the single most important health care intervention in the industrialized

world’. (Avorn 2010)

Avorn, J., 2010. Medication Use in Older Patients: Better Policy Could Encourage Better Practice. JAMA 304, 1606-1607. 7

Age Related Medicines Focus GroupAPS can provide the framework for collaboration• Web site• Access to membership and Linked-in contact networks• Links with other Focus Groups• Support (financial and organisational) for workshops / conferences /

symposia• APS Pharm Sci 2014 Conference September • Potential for session at FIP Conference Bangkok (August 2014)Outcome from meeting• Ownership going forward

– Committee identified

• Next steps agreed

It’s your meeting we’re here to facilitate!8